8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer)
Published . Updated .
Filed: 2026-10-09 AccNo: 0001193125-26-418417 Size: 146 KB Item 8.01: Other Events
Directly affected
- RNA Atrium Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-09 AccNo: 0001193125-26-418417 Size: 146 KB Item 8.01: Other Events
Source: sec-edgar
Atrium Therapeutics (RNA) since this story, compared with the market
Since the first closing price after “8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer),” Atrium Therapeutics (RNA) is -7.66%. The S&P 500 fund (SPY) is -1.47% over the same days, a -6.20% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +1.57% | final price |
| GLD | the next day | +0.93% | final price |
| GLD | two days later | +0.80% | final price |
| GLD | three days later | -0.70% | final price |
| GLD | three days earlier | +0.96% | final price |
| GLD | five days earlier | +0.41% | final price |
| QQQ | that day | +0.50% | final price |
| QQQ | the next day | -0.20% | final price |
| QQQ | two days later | -0.52% | final price |
| QQQ | three days later | -2.48% | final price |
| QQQ | three days earlier | +1.62% | final price |
| QQQ | five days earlier | +0.27% | final price |
| Atrium Therapeutics (RNA) | that day | +2.00% | final price |
| Atrium Therapeutics (RNA) | the next day | -0.24% | final price |
| Atrium Therapeutics (RNA) | two days later | -5.89% | final price |
| Atrium Therapeutics (RNA) | three days later | -6.74% | final price |
| Atrium Therapeutics (RNA) | three days earlier | -3.03% | final price |
| Atrium Therapeutics (RNA) | five days earlier | -4.85% | final price |
| SPY | that day | +0.60% | final price |
| SPY | the next day | +0.54% | final price |
| SPY | two days later | +0.54% | final price |
| SPY | three days later | -0.55% | final price |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | -0.55% | final price |
| TLT | that day | +0.12% | final price |
| TLT | the next day | +0.21% | final price |
| TLT | two days later | +0.62% | final price |
| TLT | three days later | +1.30% | final price |
| TLT | three days earlier | -0.76% | final price |
| TLT | five days earlier | -0.49% | final price |
Who is named in “8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer)”
Companies carried with this story
- RNA Atrium Therapeutics
In “8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer),” Atrium Therapeutics (RNA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RNA
How “8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer)” reaches Atrium Therapeutics (RNA)
The 9 Oct 2026 story “8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer)” names Atrium Therapeutics (RNA) because of this story.
The link for Atrium Therapeutics (RNA) is this: SEC 8-K filing -> direct issuer disclosure -> RNA
Dates and price levels for Atrium Therapeutics (RNA)
RNA traded between 7.50 and 8.51 across 8 sessions. The latest close on file is 7.59.
A simple score for Atrium Therapeutics (RNA)
16 out of 100
“8-K/A - Atrium Therapeutics, Inc. (0002093101) (Filer)” scores 16 out of 100. The score uses 1 sources, a -0.78% difference versus the S&P 500 (SPY), and 1 linked companies.